Many drugs show neuroprotective effects for stroke treatment, including NMDA receptor antagonist, calcium antagonists, and pituitary adenylate cyclase-activating polypeptide (PACAP) [15, 16]. This evidence concerns the gene ADCYAP1 and stroke disorder.